Cargando…
PGK1 contributes to tumorigenesis and sorafenib resistance of renal clear cell carcinoma via activating CXCR4/ERK signaling pathway and accelerating glycolysis
Phosphoglycerate kinase 1 (PGK1) has complicated and multiple functions in cancer occurrence, tumor progression and drug resistance. Sorafenib is the first-line treatment targeted drug for patients with kidney renal clear cell carcinoma (KIRC) as a tyrosine kinase inhibitor, but sorafenib resistance...
Autores principales: | He, Yu, Wang, Xixi, Lu, Weiliang, Zhang, Dan, Huang, Lan, Luo, Yang, Xiong, Li, Li, Haocheng, Zhang, Peng, Li, Qiu, Liang, Shufang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8816910/ https://www.ncbi.nlm.nih.gov/pubmed/35121728 http://dx.doi.org/10.1038/s41419-022-04576-4 |
Ejemplares similares
-
ACTL6A regulates follicle-stimulating hormone-driven glycolysis in ovarian cancer cells via PGK1
por: Zhang, Jiawen, et al.
Publicado: (2019) -
PTCSC3‐mediated glycolysis suppresses thyroid cancer progression via interfering with PGK1 degradation
por: Jiang, Bo, et al.
Publicado: (2021) -
PGK1 as Predictor of CXCR4 Expression, Bone Marrow Metastases and Survival in Neuroblastoma
por: Ameis, Helen M., et al.
Publicado: (2013) -
Esculetin Inhibits Cancer Cell Glycolysis by Binding Tumor PGK2, GPD2, and GPI
por: Wu, Song-Tao, et al.
Publicado: (2020) -
O-GlcNAcylation of PGK1 coordinates glycolysis and TCA cycle to promote tumor growth
por: Nie, Hao, et al.
Publicado: (2020)